Search results: Sage Journals

Open accessResearch articleFirst published July, 2018

A randomized trial of the efficacy and safety of azilsartan medoxomil combined with chlorthalidone

Michael A Weber, Peter Sever, Attila Juhasz [...]

Journal of the Renin-Angiotensin-Aldosterone System

Restricted accessResearch articleFirst published December, 2011

Azilsartan Medoxomil: A New Angiotensin II Receptor Antagonist for Treatment of Hypertension

William L Baker, William B White

Annals of Pharmacotherapy

Restricted accessResearch articleFirst published 2025

Molecular docking-guided experimental evaluation of Azilsartan gel as therapeutic potential in a rat burn model

Hawkar Qadir Baiz, Aram Ismael Ibrahim, Hemn Hassan Othman [...]

Journal of the Renin-Angiotensin-Aldosterone System

Restricted accessResearch articleFirst published March, 2014

Ability of the new AT 1 receptor blocker azilsartan to block angiotensin II-induced AT 1 receptor activation after wash-out

Shin-ichiro Miura, Yoshino Matsuo, Asuka Nakayama [...]

Journal of the Renin-Angiotensin-Aldosterone System

Open accessResearch articleFirst published January, 2023

Azilsartan suppresses the antiapoptotic biomarker and pro-inflammatory cytokines in rat model of cisplatin-induced retinal and optic nerve toxicity

Noor Majid Raheem, Naza Mohammed Ali Mahmood

Human & Experimental Toxicology

Restricted accessResearch articleFirst published May, 2013

Azilsartan Medoxomil/Chlorthalidone: A New Fixed-Dose Combination Antihypertensive

Danielle Pierini, Katherine Vogel Anderson

Annals of Pharmacotherapy

Open accessResearch articleFirst published 2014

Spectrophotometric and Spectrofluorimetric Studies on Azilsartan Medoxomil and Chlorthalidone to be Utilized in Their Determination in Pharmaceuticals

Walid M. Ebeid, Ehab F. Elkady, Asmaa A. El-Zaher [...]

Analytical Chemistry Insights

Open accessResearch articleFirst published January, 2019

The angiotensin II type 1 receptor blocker azilsartan can overwhelm the sympathetic nerve activation stimulated by coadministration of calcium channel blockers

Michio Fukuda, Yukako Isobe-Sasaki, Ryo Sato [...]

Journal of the Renin-Angiotensin-Aldosterone System

Open accessResearch articleFirst published 2026

Newfangled Combination Azilsartan and Ceftriaxone Exhibited Potential Effects in In-Vitro and In-Vivo Models of Cerebral Ischemia: A Comprehensive Pharmacological Investigation

Gaddam Narasimha Rao, Srikanth Jupudi, Devarakonda Krishna Prasad [...]

Annals of Neurosciences

Restricted accessResearch articleFirst published 2026

Comparative efficacy of angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in preclinical renal ischemia-reperfusion injury models: Multilevel and network meta-analyses

Selda Emre Aydıngöz, Ariyan Teimoori, Murat Koçak

Journal of the Renin-Angiotensin-Aldosterone System

Open accessResearch articleFirst published July, 2018

A randomized trial of the efficacy and safety of azilsartan medoxomil combined with chlorthalidone

Michael A Weber, Peter Sever, Attila Juhasz [...]

Journal of the Renin-Angiotensin-Aldosterone System

Restricted accessResearch articleFirst published December, 2011

Azilsartan Medoxomil: A New Angiotensin II Receptor Antagonist for Treatment of Hypertension

William L Baker, William B White

Annals of Pharmacotherapy

Restricted accessResearch articleFirst published 2025

Molecular docking-guided experimental evaluation of Azilsartan gel as therapeutic potential in a rat burn model

Hawkar Qadir Baiz, Aram Ismael Ibrahim, Hemn Hassan Othman [...]

Journal of the Renin-Angiotensin-Aldosterone System

Restricted accessResearch articleFirst published March, 2014

Ability of the new AT 1 receptor blocker azilsartan to block angiotensin II-induced AT 1 receptor activation after wash-out

Shin-ichiro Miura, Yoshino Matsuo, Asuka Nakayama [...]

Journal of the Renin-Angiotensin-Aldosterone System

Open accessResearch articleFirst published January, 2023

Azilsartan suppresses the antiapoptotic biomarker and pro-inflammatory cytokines in rat model of cisplatin-induced retinal and optic nerve toxicity

Noor Majid Raheem, Naza Mohammed Ali Mahmood

Human & Experimental Toxicology

Restricted accessResearch articleFirst published May, 2013

Azilsartan Medoxomil/Chlorthalidone: A New Fixed-Dose Combination Antihypertensive

Danielle Pierini, Katherine Vogel Anderson

Annals of Pharmacotherapy

Open accessResearch articleFirst published 2014

Spectrophotometric and Spectrofluorimetric Studies on Azilsartan Medoxomil and Chlorthalidone to be Utilized in Their Determination in Pharmaceuticals

Walid M. Ebeid, Ehab F. Elkady, Asmaa A. El-Zaher [...]

Analytical Chemistry Insights

Open accessResearch articleFirst published January, 2019

The angiotensin II type 1 receptor blocker azilsartan can overwhelm the sympathetic nerve activation stimulated by coadministration of calcium channel blockers

Michio Fukuda, Yukako Isobe-Sasaki, Ryo Sato [...]

Journal of the Renin-Angiotensin-Aldosterone System

Open accessResearch articleFirst published 2026

Newfangled Combination Azilsartan and Ceftriaxone Exhibited Potential Effects in In-Vitro and In-Vivo Models of Cerebral Ischemia: A Comprehensive Pharmacological Investigation

Gaddam Narasimha Rao, Srikanth Jupudi, Devarakonda Krishna Prasad [...]

Annals of Neurosciences

Restricted accessResearch articleFirst published 2026

Comparative efficacy of angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in preclinical renal ischemia-reperfusion injury models: Multilevel and network meta-analyses

Selda Emre Aydıngöz, Ariyan Teimoori, Murat Koçak

Journal of the Renin-Angiotensin-Aldosterone System